L. Bubendorf, A. Schöpfer, U. Wagner, G. Sauter, H. Moch et al., Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients, Hum Pathol, vol.31, pp.578-83, 2000.

N. U. Lin, J. R. Bellon, and E. P. Winer, CNS metastases in breast cancer, J Clin Oncol, vol.22, pp.3608-3625, 2004.
DOI : 10.1200/jco.2004.01.175

A. Heidenreich, P. J. Bastian, J. Bellmunt, M. Bolla, S. Joniau et al., European Association of Urology. EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013, Eur Urol, vol.65, pp.124-161, 2014.

J. L. Mohler, P. W. Kantoff, A. J. Armstrong, R. R. Bahnson, M. Cohen et al., Prostate cancer, version 2, J Natl Compr Canc Netw, vol.12, pp.686-718, 2014.

E. Senkus, S. Kyriakides, S. Ohno, F. Penault-llorca, P. Poortmans et al., Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Ann Oncol, vol.26, pp.8-30, 2015.

E. Even-sapir, Imaging of malignant bone involvement by morphologic, scintigraphic, and hybrid modalities, J Nucl Med, vol.46, pp.1356-67, 2005.

G. Savelli, L. Maffioli, M. Maccauro, E. De-deckere, and E. Bombardieri, Bone scintigraphy and the added value of SPECT (single photon emission tomography) in detecting skeletal lesions, Q J Nucl Med, vol.45, pp.27-37, 2001.

H. Schirrmeister, G. Glatting, J. Hetzel, K. Nüssle, C. Arslandemir et al., Prospective evaluation of the clinical value of planar bone scans, SPECT, and (18)F-labeled NaF PET in newly diagnosed lung cancer, J Nucl Med, vol.42, pp.1800-1804, 2001.

L. Giovanella, M. Castellani, S. Suriano, T. Ruberto, L. Ceriani et al., Multi-field-of-view SPECT is superior to whole-body scanning for assessing metastatic bone disease in patients with prostate cancer, Tumori, vol.97, pp.629-662, 2011.

W. Römer, A. Nömayr, M. Uder, W. Bautz, and T. Kuwert, SPECTguided CT for evaluating foci of increased bone metabolism classified as indeterminate on SPECT in cancer patients, J Nucl Med, vol.47, pp.1102-1108, 2006.

V. Helyar, H. K. Mohan, T. Barwick, L. Livieratos, G. Gnanasegaran et al., The added value of multislice SPECT/CT in patients with equivocal bony metastasis from carcinoma of the prostate, Eur J Nucl Med Mol Imaging, vol.37, pp.706-719, 2010.

X. Ndlovu, R. George, A. Ellmann, and J. Warwick, Should SPECT-CT replace SPECT for the evaluation of equivocal bone scan lesions in patients with underlying malignancies, Nucl Med Commun, vol.31, pp.659-65, 2010.

Y. Zhang, H. Shi, Y. Gu, Y. Xiu, B. Li et al., Differential diagnostic value of single-photon emission computed tomography/spiral computed tomography with Tc-99m-methylene diphosphonate in patients with spinal lesions, Nucl Med Commun, vol.32, pp.1194-200, 2011.

L. Jiang, L. Han, H. Tan, P. Hu, Y. Zhang et al., Diagnostic value of 99 mTc-MDP SPECT/spiral CT in assessing indeterminate spinal solitary lesion of patients without malignant history, Ann Nucl Med, vol.27, pp.460-467, 2013.

G. J. Cook, G. Azad, and A. R. Padhani, Bone imaging in prostate cancer: the evolving roles of nuclear medicine and radiology, Clin Transl Imaging, vol.4, pp.439-486, 2016.

P. Sharma, H. Singh, R. Kumar, C. Bal, S. Thulkar et al., Bone scintigraphy in breast cancer: added value of hybrid SPECT-CT and its impact on patient management, Nucl Med Commun, vol.33, pp.139-186, 2012.

M. Tuncel, E. Lay-ergun, C. Tuncali, and M. , Clinical impact of SPECT-CT on bone scintigraphy in oncology: Pattern approach, J BUON, vol.21, pp.1296-306, 2016.

H. Palmedo, C. Marx, A. Ebert, B. Kreft, Y. Ko et al., Whole-body SPECT/CT for bone scintigraphy: diagnostic value and effect on patient management in oncological patients, Eur J Nucl Med Mol Imaging, vol.41, pp.59-67, 2014.
DOI : 10.1007/s00259-013-2532-6

C. Guezennec, N. Keromnes, P. Robin, R. Abgral, D. Bourhis et al., Incremental diagnostic utility of systematic double-bed SPECT/CT for bone scintigraphy in initial staging of cancer patients, Cancer Imaging, vol.17, p.16, 2017.

L. Herzig, T. Bischoff, B. Favrat, P. Vaucher, B. Gencer et al.,

, Revue Medicale Suisse, vol.295, pp.1082-1083, 2011.

O. Rager, R. Nkoulou, N. Exquis, V. Garibotto, C. Tabouretviaud et al., Whole-Body SPECT/CT versus Planar Bone Scan with Targeted SPECT/CT for Metastatic Workup, BioMed Research International, p.7039406, 2017.

I. Jambor, A. Kuisma, S. Ramadan, R. Huovinen, M. Sandell et al., Prospective evaluation of planar bone scintigraphy, SPECT, SPECT/ CT, 18F-NaF PET/CT and whole body 1.5T MRI, including DWI, for the detection of bone metastases in high risk breast and prostate cancer patients: SKELETA clinical trial, Acta Oncol, vol.55, pp.59-67, 2016.

J. Löfgren, J. Mortensen, S. H. Rasmussen, C. Madsen, A. Loft et al., A prospective study comparing (99m)Tc-HDP planar bone scintigraphy and whole-body SPECT/CT with (18)F-fluoride PET/CT and (18)F-fluoride PET/MRI for diagnosing bone metastases, J Nucl Med, vol.58, pp.1778-1785, 2017.

G. Abikhzer, K. Gourevich, O. Kagna, O. Israel, A. Frenkel et al., Whole-body bone SPECT in breast cancer patients: the future bone scan protocol, Nuclear Medicine Communications, vol.37, pp.247-253, 2016.